SGMT vs WH · rev $2.0M vs P/E 20, rev $1.43B
Sagimet Biosciences Inc. Series A Common Stock (SGMT) versus Wyndham Hotels & Resorts Inc (WH) — a side-by-side from cached financials, not a winner call.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Wyndham Hotels & Resorts Inc (WH) is a lodging company listed on US.
Latest reported SGMT revenue for 2023-09-30 was $2.0M. Net income was -$6.4M. Revenue was up 0.0% from 2023-07-31 to 2023-09-30. SGMT currently screens at market cap $403.2M.
Latest reported WH revenue for 2025-12-31 was $1.43B. Net income was $193.0M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. WH currently screens at market cap $6.51B and trailing P/E 20.1.
SGMT currently screens at market cap $403.2M. WH currently screens at market cap $6.51B and trailing P/E 20.1.
Not investment advice. Open the SGMT and WH stock pages for the full models.
Not investment advice.